The federal government has unveiled plans for local production of vaccines and, in particular, to reduce dependence on imported pharmaceuticals.
Minister of State for Health and Social Welfare, Dr. Tunji Alausa, said this during a Stakeholder Dialogue aimed at bridging generational gaps in Nigeria’s pharmaceutical and vaccine sectors, with the African Pharmaceutical Technology Foundation (APTF) and the World Health Organization (WHO). . ) in Abuja.
The discussion aims to synthesize concepts, responses, and contextual methods that will drive the generational movement for local manufacturing of medicines and vaccines.
This approach, the minister said, would provide a solid foundation for harnessing local capacities to meet people’s desires for physical care, adding that the intervention would also stimulate local studies and progression activities for prescription drugs and other fitness products.
“Nigeria, like many African countries, has been affected by the inability to manufacture vaccines locally. In view of this, the Minister of Health and Social Welfare, Professor Pate Ali, has developed a vaccination policy to be proactive in achieving this. Sustainable local manufacturing of vaccines.
“This progression of this era of policy-making has been carried out together with key actors in the health sector and will be an adapted and appropriate reaction to the lack of access that Nigeria and other equally disadvantaged countries have experienced to two vaccines. Pressure research likely did, due to the COVID-19 pandemic, Dr. Alausa explained.
He said: “With the measures taken so far, I am confident that the government’s priority on vaccine production will start to generate the desired result in the shortest imaginable time. Reliance on imported prescription drugs will be dramatically minimized.
The director general of the National Institute for Pharmaceutical Research and Development (NIPRD), Dr. Obi Adigwe, said the institute sought to lead the pace and coordinate science and allow industry policies to protect at least three local vaccine production entities. within 3 to 5 years.
He expressed optimism that the policy echo formula will allow them to achieve the goal of three productive entities in part of the time planned.
“Three corporations have expressed interest and have spoken to their managers and presidents. Depending on the case, and given the integrity of those people, I know that those three corporations will effectively manufacture vaccines within 24 to 36 months.
“So it’s up to us in our activities to make sure that their help is contextual and allows them to reach that goal,” he said.
© 2024 Leadership Media Group – All rights reserved.